Founded in 2003 by a group of scientists from the University of California, Berkeley, Amyris uses new science and an innovative business model to address global sustainability challenges. Amyris utilises yeast to develop and manufacture high performing, cost competitive and sustainable alternatives to chemical and petroleum-based products.
From its original technology for anti-malarial treatments, to its recently-introduced renewable jet fuel, to sustainable alternatives for the cosmetics and personal care industry, Amyris is looking to set new standards for a more sustainable world. Amyris was awarded the prestigious 2014 Presidential Green Chemistry Award from the US Environmental Protection Agency (EPA).
In 2005, Amyris started developing microbial strains to produce a precursor to Artemisinin, the key ingredient in an effective anti-malarial drug. Funded by the Bill & Melinda Gates Foundation, the project has provided technology responsible for more than 120 million malaria treatments to date.
Building on this success, Amyris has been applying its innovative platform to the production of a portfolio of commercial products based on Biofene®, the company’s brand of farnesene. To further its global mission, Amyris initially focused on developing renewable fuels, with goals of helping to reduce the world’s dependence on petroleum and contributing to reductions in greenhouse gas emissions. Amyris also developed and introduced sustainably produced flavours and fragrances, as well as renewable solvents, lubricants and polymers. Now Amyris is providing the cosmetic industry with costcompetitive alternatives to unsustainable ingredients in consumer care products. Amyris’s leading cosmetic products are derived from a renewable source.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
